BrightSpring Health Services, Inc. (NASDAQ:BTSG – Get Free Report) has been given an average rating of “Buy” by the twenty analysts that are covering the stock, MarketBeat Ratings reports. Eighteen equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $70.71.
Several analysts have recently weighed in on BTSG shares. Guggenheim began coverage on BrightSpring Health Services in a report on Monday, July 13th. They issued a “buy” rating and a $81.00 target price for the company. Wells Fargo & Company raised their price target on BrightSpring Health Services from $61.00 to $78.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. KeyCorp reaffirmed an “overweight” rating on shares of BrightSpring Health Services in a research report on Monday, August 3rd. Weiss Ratings reiterated a “buy (b-)” rating on shares of BrightSpring Health Services in a research note on Friday, July 31st. Finally, The Goldman Sachs Group initiated coverage on BrightSpring Health Services in a report on Monday, June 8th. They issued a “buy” rating and a $71.00 price objective for the company.
Check Out Our Latest Stock Analysis on BTSG
Institutional Trading of BrightSpring Health Services
BrightSpring Health Services Stock Up 0.9%
BTSG stock opened at $57.26 on Friday. The company has a current ratio of 1.59, a quick ratio of 1.22 and a debt-to-equity ratio of 1.06. BrightSpring Health Services has a twelve month low of $27.11 and a twelve month high of $73.75. The company’s 50 day moving average is $60.51 and its two-hundred day moving average is $57.96. The stock has a market cap of $11.33 billion, a P/E ratio of 34.49, a PEG ratio of 0.66 and a beta of 1.87.
BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) last announced its quarterly earnings results on Friday, July 31st. The company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.40 by $0.05. BrightSpring Health Services had a net margin of 2.55% and a return on equity of 16.73%. The firm had revenue of $3.87 billion for the quarter, compared to analyst estimates of $3.66 billion. During the same period last year, the business earned $0.22 EPS. BrightSpring Health Services’s revenue for the quarter was up 23.0% compared to the same quarter last year. Research analysts expect that BrightSpring Health Services will post 1.82 earnings per share for the current fiscal year.
BrightSpring Health Services Company Profile
BrightSpring Health Services, Inc is a U.S. provider of pharmacy and health services focused on individuals with complex or chronic medical needs. The company delivers care across home and community-based settings, serving older adults, people with disabilities, and patients requiring specialized support.
Its services include pharmacy care through PharMerica, home health and hospice, primary and urgent care, behavioral health, rehabilitation, and personal care. BrightSpring also provides residential and community-based services, including assistance with daily living, clinical support, and care coordination for individuals who need ongoing support outside traditional hospital settings.
The company was formed in 2019 through the combination of PharMerica and ResCare.
Featured Stories
- Five stocks we like better than BrightSpring Health Services
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Appleās $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.
